PLAG1 and neoplasm: Most of these recent developments were represented by diverse recurrent oncogene fusions as driver events in distinct subsets of neoplasms of well established (endometrial stromal [1]) origin or of ambiguous (PLAG1, NTRK fusions and others [2, 3, 5]) histogenetic origin.